2023 for FDA is disappointing as well, sales stalling in Italy. This could take much longer than I first thought. The release of some endometriosis was the item I have been most interested in and am looking forward to those results but considering the hoops its taken to get the Kidney test through not expecting anything quick there either. Lightened my load a little further today. Been in since the .30s so its been a winner regardless and I still like the company and respect their resource management but this could be a long row. I'll look again when the Q1 results come through, for me, thats still the most exciting part. If they can get some cash coming in the door with a second test in the wings that that will be a game changer. I'll be back at some point but not at this price.
PIQ Price at posting:
95.0¢ Sentiment: Sell Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)